The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance therapy with olaparib or selumetinib plus durvalumab (S+D) according to genetic profile of metastatic pancreatic adenocarcinoma (m-PDAC) controlled with modified FOLFIRINOX (mFFX): A phase II randomized MAZEPPA GERCOR D19-02 PRODIGE-72 study.
 
Pascal Hammel
Consulting or Advisory Role - AstraZeneca (Inst); ERYTECH Pharma (Inst); IPSEN (Inst); Mylan; Rafael Pharmaceuticals; Servier/Pfizer; VECT-HORUS
Speakers' Bureau - AstraZeneca; Mylan; SERVIER
Research Funding - AstraZeneca (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Halozyme (Inst)
Travel, Accommodations, Expenses - Halozyme; Ipsen; Pfizer/EMD Serono; Shire; Vect-Horus
 
Meher Ben Abdelghani
Consulting or Advisory Role - Bayer; BMS; Deciphera; Incyte; Merck Serono; Mundipharma; Pierre Fabre; SERVIER; viatris
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER; Viatris
 
Gael Roth
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Ipsen; MSD Oncology; SERVIER; Viatris
Research Funding - Genoscience Pharma (Inst); Netris Pharma (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb/Medarex; Ipsen; SERVIER; Viatris
 
Ayhan Ulusakarya
No Relationships to Disclose
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Clemence Toullec
Honoraria - Amgen; Bayer; Bristol-Myers Squibb/Celgene; Ipsen; MSD; Pierre Fabre; Sanofi; SERVIER
Consulting or Advisory Role - AstraZeneca; Merck Serono
Research Funding - Bristol-Myers Squibb/Medarex (Inst)
Travel, Accommodations, Expenses - Accord Healthcare; Amgen; AstraZeneca; Bristol-Myers Squibb/Celgene; Ipsen; Merck Serono; Merck Serono; Sanofi; SERVIER
 
Christophe Borg
Consulting or Advisory Role - Bayer; MSD Oncology; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
 
Olivia Hentic Dhome
Honoraria - AAA HealthCare; IPSEN; Keocyt
Travel, Accommodations, Expenses - AAA HealthCare; Ipsen
 
Isabelle Trouilloud
Honoraria - SERVIER
 
Laetitia Dahan
No Relationships to Disclose
 
Sandrine Hiret
Consulting or Advisory Role - AstraZeneca; BMS; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Novartis; Roche; Sanofi
 
Olivier Bouche
Consulting or Advisory Role - Amgen; Apmonia Therapeutics; Bayer; Deciphera; MSD Oncology; Pierre Fabre; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; MSD Oncology; Pierre Fabre; Servier
Travel, Accommodations, Expenses - MSD Oncology; Servier
 
Yves Rinaldi
Honoraria - Amgen Astellas BioPharma; VIATRIS
 
Jean-Frédéric Blanc
No Relationships to Disclose
 
Christelle De La Fouchardiere
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Daichi-Sankyo; Eisai; Ipsen; Lilly; MSD Oncology; Pierre Fabre; Roche/Genentech; SERVIER
Research Funding - MSD (Inst); Natera (Inst); Pierre Fabre (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; MSD Oncology; Pierre Fabre; Roche; SERVIER
 
Cindy Neuzillet
Honoraria - Amgen; AstraZeneca; Baxter; Bristol-Myers Squibb; Fresenius Kabi; Incyte; Merck; MSD Oncology; Novartis; Nutricia; Pierre Fabre; SERVIER
Consulting or Advisory Role - OSE Immunotherapeutics
Research Funding - AstraZeneca (Inst); Fresenius Kabi (Inst); Nutricia (Inst); OSE Immunotherapeutics (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pierre Fabre
 
Maud Kamal
No Relationships to Disclose
 
Antoine Falcoz
No Relationships to Disclose
 
Anthony Turpin
No Relationships to Disclose
 
Rosine Guimbaud
No Relationships to Disclose